Diacerein as adjuvant to diclofenac sodium in osteoarthritis knee

International Journal of Rheumatic Diseases

Volumn 15, Issue 1, 2012, Pages 69-77

  Singh, Kuljinder ^a   Sharma, Rakesh ^a   Rai, Jaswant ^a  

^a GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

Diacerein; Diclofenac sodium; Nonsteroidal anti inflammatory drugs; Osteoarthritis; RCT; SYSDOA

Indexed keywords

DIACEREIN; DICLOFENAC; PARACETAMOL;

ADJUVANT THERAPY; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FUNCTIONAL ASSESSMENT; GENERAL CONDITION IMPROVEMENT; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ACETAMINOPHEN; ADMINISTRATION, ORAL; ANALGESICS, NON-NARCOTIC; ANTHRAQUINONES; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRALGIA; CAPSULES; DELAYED-ACTION PREPARATIONS; DICLOFENAC; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INDIA; KNEE JOINT; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN MEASUREMENT; PLACEBOS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RANGE OF MOTION, ARTICULAR; RECOVERY OF FUNCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84857042247     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2011.01648.x     Document Type: Article

References (27)

1. Woolf AD, Pfleger B (2003) Burden of major musculoskeletal conditions. Bull World Health Org81, 646-56.
2. Rubin BR (2001) Osteoarthritis. J Am Osteopath Assoc101(4 Suppl. Pt 2), S2-5.
3. Brandt KD (1988) Osteoarthritis. Clin Geriatr Med4, 279-93.
4. Chopra A, Patil J, Billempelly V, Relwani J, Tandle HS (2001) Prevalence of rheumatic diseases in a rural population in western India: a WHO-ILAR COPCORD Study. J Assoc Physicians India49, 240-6.
5. Ndongo S, Ka MM, Leye A, et al. (2003) [Epidemiological and clinical features of the knee osteoarthritis]. Dakar Med48, 171-5.
6. Sarzi-Puttini P, Cimmino MA, Scarpa R, et al. (2005) Osteoarthritis: an overview of the disease and its treatment strategies. Semin Arthritis Rheum35(Suppl. 1), 1-10.
7. Singh G (2003) Treatment options for osteoarthritis. Surg Technol Int11, 287-92.
8. Dingle JT (1991) Cartilage maintenance in osteoarthritis: interaction of cytokines, NSAID and prostaglandins in articular cartilage damage and repair. J Rheumatol28(Suppl.), 30-7.
9. Pelletier JP, Mineau F, Fernandes JC, Duval N, Martel-Pelletier J (1998) Diacerhein and rhein reduce the interleukin 1beta stimulated inducible nitric oxide synthesis level and activity while stimulating cyclooxygenase-2 synthesis in human osteoarthritic chondrocytes. J Rheumatol25, 2417-24.
10. Martel-Pelletier J, Mineau F, Jolicoeur FC, Cloutier JM, Pelletier JP (1998) In vitro effects of diacerhein and rhein on interleukin 1 and tumor necrosis factor-alpha systems in human osteoarthritic synovium and chondrocytes. J Rheumatol25, 753-62.
11. Tamura T, Shirai T, Kosaka N, Ohmori K, Takafumi N (2002) Pharmacological studies of diacerein in animal models of inflammation, arthritis and bone resorption. Eur J Pharmacol448, 81-7.
12. Hunter DJ, Wise B (2007) Review: diacerein is more effective than placebo and is as effective as NSAIDs for knee and hip osteoarthritis. Evid Based Med12, 74.
13. Kellgren JH, Lawrence JS (1957) Radiological assessment of osteoarthrosis. Ann Rheum Dis16, 494e502.
14. Altman R, Asch E, Bloch D, et al. (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum29, 1039e49.
15. Zheng WJ, Tang FL, Li J, et al. (2006) Evaluation of efficacy and safety of diacerein in knee osteoarthritis in Chinese patients. Chin Med Sci J21, 75-80.
16. Louthrenoo W, Nilganuwong S, Aksaranugraha S, Asavatanabodee P, Saengnipanthkul S, Thai Study Group (2007) The efficacy, safety and carry-over effect of diacerein in the treatment of painful knee osteoarthritis: a randomised, double-blind, NSAID-controlled study. Osteoarthritis Cartilage15, 605-14.
17. Mangat G, Balakrishnan C, Venkatachalm S, Joshi VR (1995) Pattern of osteoarthritis(OA) in India: a hospital based study. J Indian Rheumatol Assoc3, 125-8.
18. Tukker A, Visscher T, Picavet H (2008) Overweight and health problems of the lower extremities: osteoarthritis, pain and disability. Public Health Nutr1, 1.
19. Pelletier JP, Yaron M, Haraoui B, et al. (2000) Efficacy and safety of diacerein in osteoarthritis of the knee: a double-blind, placebo-controlled trial. The Diacerein Study Group. Arthritis Rheum43, 2339-48.
20. Provvedini D, Cohen P (2002) Efficacy of diacerein on the symptoms and radiographic progression of osteoarthritis. Presse Med31, 4S13-5.
21. Mazzaro C, Bocchieri E, Tesolin GF, Ventre L, Romagnoli A (1989) [Clinical evaluation of diacerein in the treatment of osteoarthrosis]. Minerva Med80, 1025-7.
22. Fidelix TSA, Soares B, Fernandes Moça, Trevisani V (2006) Diacerein for osteoarthritis. Cochrane Database of Syst Rev (1), Art. No.: CD005117. DOI:
23. Sharma A, Rathod R, Baliga VP (2008) An open prospective study on postmarketing evaluation of the efficacy and tolerability of diacerein in osteo-arthritis of the knee (DOK). J Indian Med Assoc106, 54-6, 58.
24. Pavelka K, Trc T, Karpas K, et al. (2007) The efficacy and safety of diacerein in the treatment of painful osteoarthritis of the knee: a randomized, multicenter, double-blind, placebo-controlled study with primary end points at two months after the end of a three-month treatment period. Arthritis Rheum56, 4055-64.
25. Rintelen B, Neumann K, Leeb BF (2006) A meta-analysis of controlled clinical studies with diacerein in the treatment of osteoarthritis. Arch Intern Med166, 1899-906.
26. Brandt KD (2006) Studies in animal models of osteoarthritis as predictors of a structure-modifying effect of diacerhein in humans with osteoarthritis. Biorheology43, 589-94.
27. Spencer CM, Wilde MI (1997) Diacerein. Drugs53, 98-106.